Stock Alert: Applied DNA Sciences Jumps 30% After Getting EUA For Covid-19 Testing Kit

Shares of Applied DNA Sciences, Inc. (APDN) are currently gaining over 30% on Friday morning after the U.S. FDA approved Emergency Use Authorization for expanded used of its COVID-19 testing kit.

APDN is currently trading at $11.56, up $2.85 or 32.72%, on the Nasdaq.

Applied DNA Sciences said FDA granted an Emergency Use Authorization amendment that both expands the installed base of PCR equipment platforms that can process the company's LineaTM COVID-19 Assay Kit and introduces automation to significantly increase the throughput of the assay by use of robotic RNA extraction.

The EUA amendment extends the RT-PCR platform authorization from the Applied Biosystems QuantStudio Dx to include Applied Biosystems' QuantStudio 5 Real-Time PCR system.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Integrated energy company Chevron reported Friday that profit for the fourth quarter increased 25 percent from last year, reflecting 17 percent revenue growth amid higher realizations and higher margins on refined product sales. Adjusted earnings per share missed analysts' estimates, while quarterly revenues topped it. Reno, Nevada-based ZLINE Kitchen and Bath has expanded its recall of gas ranges citing serious risk of injury or death from carbon monoxide poisoning, the U.S. Consumer Product Safety Commission announced. The recall now includes about 30,000 units of ZLINE gas ranges, including about 28,000 units... The Food and Drug Administration's independent advisory committee unanimously recommended replacing the current original COVID vaccines used in the U.S. for primary shots with new bivalent omicron shots authorized as boosters, reports said. The committee also considered the proposal for annual COVID vaccination, however, didn't vote on it.
Follow RTT